Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Consolidated Health Economic Evaluation Reporting Standards
82%
Health Economic Evaluation
62%
Reporting Guidance
59%
Crohn's Disease
42%
Israel
39%
Cost-effectiveness
30%
Economic Evaluation
28%
Quality-adjusted Life Years
26%
Cost-effectiveness Analysis
25%
Cost-utility Analysis
23%
Health Care Services
20%
Israeli
18%
Willingness to Pay
16%
Acute Myocardial Infarction
15%
Oncology
14%
Health Intervention
14%
Peer Reviewers
13%
Health Systems
12%
Atrial Fibrillation
12%
Risk Sharing
12%
Ulcerative Colitis
12%
Peer-reviewed Journals
11%
Healthcare Costs
11%
Economic Status
11%
Quality of Life
10%
Hospitalization
9%
Healthcare Utilization
9%
Inflammatory Bowel Disease
9%
Inflammatory Bowel Disease Questionnaire
9%
Social Support
9%
Randomized Controlled Trial
9%
Disease Activity
8%
Incremental Cost-effectiveness Ratio
8%
Psychological Symptoms
8%
Reporting Requirements
8%
Harvey-Bradshaw Index
8%
Treatment Costs
8%
Short Form 36 (SF-36)
8%
Public Healthcare
8%
Social Care
8%
Planning Study
8%
Stakeholder Involvement
8%
Stakeholder Roles
8%
Health Technology Assessment Bodies
8%
Public Health Education
8%
Course of Action
8%
Comparative Analysis
8%
Alternatives Analysis
8%
Publication Guidelines
8%
ISPOR
8%
Medicine and Dentistry
Health Care Cost
100%
Crohn's Disease
40%
Checklist
33%
Inflammatory Bowel Disease
27%
Diseases
25%
Patient with Crohn's Disease
25%
Quality of Life
22%
Ulcerative Colitis
20%
Malignant Neoplasm
16%
Quality Adjusted Life Year
16%
Cost-Effectiveness Analysis
15%
Short Form 36
15%
Systematic Review
14%
Health Service
14%
Oncology
13%
Health Care
13%
Restenosis
10%
Decision Making
9%
Congestive Heart Failure
9%
Atrial Fibrillation
9%
Acute Heart Infarction
9%
Randomized Controlled Trial
9%
Myocardial Infarction
9%
Risk Management
9%
Mental Health
8%
Patient Referral
8%
Primary Health Care
8%
Cardiovascular System
7%
Drug Therapy
7%
Anticoagulation
7%
Disease Activity
7%
Brief Symptom Inventory
7%
Family Assessment
7%
Drug-Eluting Stent
6%
Carcinoembryonic Antigen
6%
Oncologist
6%
Oral
6%
Patient with Ulcerative Colitis
6%
Orthopedics
6%
Direct Oral Anticoagulant
6%
Inguinal Hernia
6%
Appendectomy
6%
Infliximab
6%
Hernioplasty
6%
Family Relation
6%
Medical Device
5%
Nursing and Health Professions
Quality Adjusted Life Year
31%
Cost Effectiveness Analysis
27%
Crohn's Disease
25%
Acute Heart Infarction
24%
Diseases
23%
Cost Utility Analysis
23%
Health Care
21%
Health Care Cost
19%
Health Care Utilization
15%
Decision-Making
14%
Patient with Crohn's Disease
14%
Adherence
14%
Systematic Review
12%
Ulcerative Colitis
12%
Inflammatory Bowel Disease
11%
Odds Ratio
11%
Brief Symptom Inventory
9%
Ambulatory Care
9%
Incremental Cost-Effectiveness Ratio
8%
Emergency Ward
8%
Healthcare System
8%
Confidence Interval
8%
Patient Referral
7%
Ward
7%
Thematic Analysis
6%
Cardiovascular System
6%
Sepsis
6%
Malignant Neoplasm
6%
Quality of Life
6%
Medical Technology
6%
Carcinoembryonic Antigen
6%
Primary Medical Care
6%
Primary Health Care
6%
Patient with Ulcerative Colitis
6%
Rosiglitazone
6%
Qualitative Research
6%
Hospital Personnel
6%
Atrial Fibrillation
6%
Intensive Care
6%
Family Assessment
5%
Health Maintenance Organization
5%
Biological Product
5%
Short Form 36
5%
